Symposia Abstracts
NS20 - Emerging role of the endocannabinoid signaling in neuropsychiatric disorders
ALTERED DNA METHYLATION AT FAAH AND ALOX5 GENES AS A BASIS FOR THE DYSREGULATED ENDOCANNABINOID-EICOSANOID NETWORK IN ALZHEIMER’S DISEASE Di Francesco A., Arosio B., Gussago C., Dainese E., Mari D., D'Addario C., Maccarrone M. |
TYPE-1 CANNABINOID RECEPTORS REGULATE INFLAMMATORY NEURODEGENERATION IN MULTIPLE SCLEROSIS Rossi S., Centonze D. |
ENDOCANNABINOIDS AND EMOTIONAL MEMORY MODULATION: THE KEY ROLE OF THE BASOLATERAL COMPLEX OF THE AMYGDALA Campolongo P., Morena M., Ratano P., Cuomo V. |
THE DUAL FACE OF THE ENDOCANNABINOID SYSTEM IN SCHIZOPHRENIA: EXPERIMENTAL EVIDENCE Zamberletti E., Gabaglio M., Prini P., Speziali S., Rubino T., Parolaro D. |
THE ENDOCANNABINOID SYSTEM AND EATING DISORDERS Scherma M., Satta V., Collu R., Fattore L., Fadda P., Fratta W. |